NO20070747L - Metode for fremstilling av 2-substituerte derivater av estron og estradiol - Google Patents
Metode for fremstilling av 2-substituerte derivater av estron og estradiolInfo
- Publication number
- NO20070747L NO20070747L NO20070747A NO20070747A NO20070747L NO 20070747 L NO20070747 L NO 20070747L NO 20070747 A NO20070747 A NO 20070747A NO 20070747 A NO20070747 A NO 20070747A NO 20070747 L NO20070747 L NO 20070747L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- general formula
- preparing
- estrone
- estradiol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
Abstract
Oppfinnelsen tilveiebringer en fremgangsmåte for fremstilling av 2-substituerte derivater av østron og østradiol, som omfatter i) fremstilling av en forbindelse med den generelle formel (II) ved omsetning av en forbindelse med den generelle formel (I) i ett eller flere trinn, til en forbindelse med den generelle formel II hvor R1 er en C1-C10 alkyl-, alkenyl- eller arylgruppe; -Cl, -Br, -I, -F; -CN; -OH; eller en -OR2-, -O(CO)R2- eller -R2-OH-gruppe, hvor R2 er en alkyl- eller alkylengruppe som har 1-6 C atomer; og bindingen mellom atom 9 og 10 er en enkelt- eller dobbeltbinding; ii) aromatisering av forbindelsen med den generelle formel II til en forbindelse med den generelle formel III hvor R1 og R2 har de ovenfor definerte betydninger; og iii) eventuelt reduksjon av forbindelsen med den generelle formel III til en forbindelse med den generelle formel IV hvor R1 og R2 har de ovenfor definerte betydninger. Videre tilveiebringer oppfinnelsen flere nye forbindelser som kan være mellomprodukter i fremgangsmåten ovenfor, og fremgangsmåter for fremstilling av disse nye forbindelsene. Oppfinnelsen tilveiebringer også 2-alkoksy-østron, 2-alkoksy-østradiol eller blandinger derav, som er hovedsakelig fri for andre østrogene mellomprodukter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04103742 | 2004-08-04 | ||
PCT/EP2005/053732 WO2006013196A1 (en) | 2004-08-04 | 2005-08-01 | Process for the preparation 2-substituted-derivatives of estrone and estradiol |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070747L true NO20070747L (no) | 2007-04-23 |
Family
ID=34929415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070747A NO20070747L (no) | 2004-08-04 | 2007-02-08 | Metode for fremstilling av 2-substituerte derivater av estron og estradiol |
Country Status (20)
Country | Link |
---|---|
US (2) | US7910756B2 (no) |
EP (1) | EP1776378B1 (no) |
JP (1) | JP5075626B2 (no) |
KR (1) | KR20070040386A (no) |
CN (1) | CN1993376A (no) |
AR (1) | AR050195A1 (no) |
AT (1) | ATE447580T1 (no) |
AU (1) | AU2005268768B2 (no) |
BR (1) | BRPI0514096A (no) |
CA (1) | CA2573133C (no) |
DE (1) | DE602005017500D1 (no) |
EC (1) | ECSP077228A (no) |
ES (1) | ES2334244T3 (no) |
IL (1) | IL180381A0 (no) |
MX (1) | MX2007001340A (no) |
NO (1) | NO20070747L (no) |
RU (1) | RU2007107914A (no) |
TW (1) | TW200611909A (no) |
WO (1) | WO2006013196A1 (no) |
ZA (1) | ZA200700483B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ2008275A3 (cs) | 2008-05-05 | 2009-05-06 | Prírodovedecká Fakulta Uk | Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují |
WO2012020417A1 (en) | 2010-08-10 | 2012-02-16 | Reliance Life Sciences Pvt. Ltd. | Process for the preparation of estradiol and its derivatives |
EP2742352B1 (en) * | 2011-08-12 | 2018-02-28 | Siemens Healthcare Diagnostics Inc. | Detection of sex steroids |
CN104592339A (zh) * | 2014-12-30 | 2015-05-06 | 湖南新合新生物医药有限公司 | 雌甾-4,9-二烯-3,17-二酮的制备方法 |
CN104497088B (zh) * | 2014-12-30 | 2016-08-24 | 湖南新合新生物医药有限公司 | 19-去甲-4-雄甾烯-3,17-二酮的制备方法 |
ITUB20155260A1 (it) * | 2015-10-30 | 2017-04-30 | Ind Chimica Srl | PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one |
CN108003210A (zh) * | 2018-01-24 | 2018-05-08 | 四川理工学院 | 一种雌甾-4,9-二烯-3,17-二酮的制备方法 |
CN108997463B (zh) * | 2018-08-09 | 2021-05-14 | 四川理工学院 | 一种雌甾-4,9-二烯-3,17-二酮制备方法 |
CN112409434B (zh) * | 2020-11-27 | 2021-10-26 | 厦门欧瑞捷生物科技有限公司 | 一种去氢孕酮的合成方法 |
CN113861158B (zh) * | 2021-11-22 | 2023-02-10 | 湖南新合新生物医药有限公司 | 一种合成甲基双烯双酮关键中间体的方法 |
CN114853802B (zh) * | 2022-03-22 | 2023-11-28 | 河北康泰药业有限公司 | 一种谷内酯衍生物及其制备方法、药物组合物和应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2997488A (en) * | 1959-06-20 | 1961-08-22 | Organon | 2-methyl-19-nor-steroids |
FR1468608A (fr) * | 1960-08-04 | 1967-02-10 | Upjohn Co | 2-alpha-fluoro stéroïdes de la série de la 19-norandrostène et leur procédé d'obtention |
FR1368721A (fr) * | 1961-04-14 | 1964-08-07 | Roussel Uclaf | Dérivés de la 19-nor testostérone et procédé de préparation |
CH409944A (fr) | 1961-04-14 | 1966-03-31 | Roussel Uclaf | Procédé de préparation de dérivés de la 19-nor-testostérone |
US3519714A (en) | 1966-03-15 | 1970-07-07 | Herchel Smith | Synthesis of gona-1,3,5(10)-trienes |
US4400524A (en) * | 1981-07-28 | 1983-08-23 | The Upjohn Company | Grignard reagents prepared from 5-halopentan-2-one propylene ketals |
DE3208432A1 (de) * | 1982-03-09 | 1983-09-15 | The Upjohn Co., 49001 Kalamazoo, Mich. | Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung |
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US5521168A (en) | 1994-10-13 | 1996-05-28 | Alcon Laboratories, Inc. | Estrogen metabolites for lowering intraocular pressure |
US5998639A (en) | 1995-11-06 | 1999-12-07 | Akzo Nobel, N.V. | Sulfatation of estrogen mixtures |
IL119649A (en) * | 1995-11-30 | 2002-03-10 | Akzo Nobel Nv | Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians |
US6051726A (en) | 1997-03-13 | 2000-04-18 | Pharm-Eco Laboratories, Inc. | Synthesis of 2-alkoxyestradiols |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
JP5317381B2 (ja) | 1999-08-23 | 2013-10-16 | エントレメッド インコーポレイテッド | 高純度2−メトキシエストラジオールの生成方法 |
AU8838601A (en) | 2000-11-27 | 2002-06-03 | Entremed Inc | Antiangiogenic agents |
-
2005
- 2005-07-14 TW TW094123942A patent/TW200611909A/zh unknown
- 2005-08-01 ES ES05767940T patent/ES2334244T3/es active Active
- 2005-08-01 RU RU2007107914/04A patent/RU2007107914A/ru not_active Application Discontinuation
- 2005-08-01 JP JP2007524335A patent/JP5075626B2/ja not_active Expired - Fee Related
- 2005-08-01 WO PCT/EP2005/053732 patent/WO2006013196A1/en active Application Filing
- 2005-08-01 DE DE602005017500T patent/DE602005017500D1/de active Active
- 2005-08-01 EP EP05767940A patent/EP1776378B1/en active Active
- 2005-08-01 BR BRPI0514096-0A patent/BRPI0514096A/pt not_active IP Right Cessation
- 2005-08-01 CA CA2573133A patent/CA2573133C/en not_active Expired - Fee Related
- 2005-08-01 AU AU2005268768A patent/AU2005268768B2/en not_active Ceased
- 2005-08-01 MX MX2007001340A patent/MX2007001340A/es active IP Right Grant
- 2005-08-01 AT AT05767940T patent/ATE447580T1/de not_active IP Right Cessation
- 2005-08-01 KR KR1020077002976A patent/KR20070040386A/ko not_active Application Discontinuation
- 2005-08-01 US US11/659,147 patent/US7910756B2/en not_active Expired - Fee Related
- 2005-08-01 CN CNA2005800261640A patent/CN1993376A/zh active Pending
- 2005-08-04 AR ARP050103233A patent/AR050195A1/es unknown
-
2006
- 2006-12-27 IL IL180381A patent/IL180381A0/en unknown
-
2007
- 2007-01-16 ZA ZA200700483A patent/ZA200700483B/xx unknown
- 2007-02-05 EC EC2007007228A patent/ECSP077228A/es unknown
- 2007-02-08 NO NO20070747A patent/NO20070747L/no not_active Application Discontinuation
-
2011
- 2011-02-22 US US13/031,975 patent/US20110152544A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7910756B2 (en) | 2011-03-22 |
IL180381A0 (en) | 2007-06-03 |
ZA200700483B (en) | 2008-09-25 |
ATE447580T1 (de) | 2009-11-15 |
WO2006013196A1 (en) | 2006-02-09 |
CN1993376A (zh) | 2007-07-04 |
CA2573133A1 (en) | 2006-02-09 |
RU2007107914A (ru) | 2008-09-10 |
JP5075626B2 (ja) | 2012-11-21 |
BRPI0514096A (pt) | 2008-05-27 |
EP1776378B1 (en) | 2009-11-04 |
US20110152544A1 (en) | 2011-06-23 |
MX2007001340A (es) | 2007-03-27 |
ES2334244T3 (es) | 2010-03-08 |
AR050195A1 (es) | 2006-10-04 |
KR20070040386A (ko) | 2007-04-16 |
CA2573133C (en) | 2012-07-10 |
DE602005017500D1 (de) | 2009-12-17 |
JP2008509109A (ja) | 2008-03-27 |
AU2005268768A1 (en) | 2006-02-09 |
TW200611909A (en) | 2006-04-16 |
ECSP077228A (es) | 2007-03-29 |
AU2005268768B2 (en) | 2011-10-13 |
US20090012319A1 (en) | 2009-01-08 |
EP1776378A1 (en) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070747L (no) | Metode for fremstilling av 2-substituerte derivater av estron og estradiol | |
CA1334668C (en) | 13-alkyl-11beta-phenylgonanes | |
AU2001253427B2 (en) | A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group | |
WO2005105822A3 (en) | 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof | |
Di Matteo et al. | Synthesis and biological characterization of 3-(imidazol-1-ylmethyl) piperidine sulfonamides as aromatase inhibitors | |
FR2618783A1 (fr) | Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant | |
KR20180030204A (ko) | 담즙산 및 이의 유도체를 제조하는 방법 | |
Mizoguchi et al. | Synthesis of multiply substituted 1, 6-dihydropyridines through Cu (I)-catalyzed 6-endo cyclization | |
JP6556125B2 (ja) | 17β−ヒドロキシステロイドデヒドロゲナーゼの阻害剤としての治療的に活性な17−窒素置換エストラトリエンチアゾール誘導体 | |
CN105111244A (zh) | 二茂铁氧桥双环-[2.2.1]-庚烯类化合物 | |
WO2010141494A2 (en) | Synthesis of ezetimibe | |
Frank et al. | Synthesis of some novel D-ring-fused dioxa-and oxazaphosphorinanes in the estrone series | |
Haveli et al. | Ring opening of activated cyclopropanes with NIS/NaN3: synthesis of C-1 linked pseudodisaccharides | |
Bruttomesso et al. | Highly stereoselective synthesis of steroidal 2, 5-diketopiperazines based on isocyanide chemistry | |
EP0087359B1 (fr) | Nouveau réactif de nitrométhylation, son application à la préparation de composés nitrométhylénés et de certains de leurs dérivés et les composés nouveaux obtenus | |
WO1991018918A1 (de) | VERFAHREN ZUR HERSTELLUNG VON 10β-H-STEROIDEN | |
Nué Martínez et al. | High yield synthesis of trans-azoxybenzene versus 2-isopropoxy-4-nitrobenzoic acid: influence of temperature and base concentration | |
JP4913389B2 (ja) | アセトキシキャビコールアセテート類縁体化合物、その製造方法、および抗アレルギー剤 | |
EP1743902A1 (en) | Method for producing 5alpha-pregnane derivative | |
Williams et al. | Synthesis of the aglycone of 26-O-deacetyl pavoninin-5 | |
Zhuang et al. | Synthesis of Novel Oximes of 2‐Aryl‐6‐methoxy‐3, 4‐dihydronaphthalene and Their Evaluation as Inhibitors of 17α‐Hydroxylase‐C17, 20‐Lyase (P450 17) | |
Nagaoka et al. | C (10)–C (19) bond cleavage reaction of 19-oxygenated androst-4-ene-3, 6-dione steroids under various conditions | |
KR960000916A (ko) | 심장혈관계 질환에 유효한 히드라지노 및 히드록시아미노-14β-히드록시안드로스탄 유도체와 이들의 제조방법 그리고 이를 함유하는 약제 조성물 | |
EP2354150A1 (en) | Process for the preparation of gestodene | |
Alam et al. | Synthesis, characterization, and cytotoxicity of N-2′-hydroxyethyl-substituted azastigmastanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |